Larvol Delta - Viracta-Therapeutics-Announces-Publication-in-Blood-Advances-Demonstrating-Promising-and-Durable-Signal-of-Nanaval-Efcacy-in-Patients-with-Relapsed-or-Refractory-RR-EpsteinBarr-VirusPositive-EBV-Lymphoma

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2023/08/08/2720649/0/en/Viracta-Therapeutics-Announces-Publication-in-Blood-Advances-Demonstrating-Promising-and-Durable-Signal-of-Nana-val-Efficacy-in-Patients-with-Relapsed-or-Refractory-R-R-Epstein-Bar.html

Aug 8, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next